1. Home
  2. FTI vs INSM Comparison

FTI vs INSM Comparison

Compare FTI & INSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TechnipFMC plc

FTI

TechnipFMC plc

N/A

Current Price

$59.15

Market Cap

27.8B

Sector

Industrials

ML Signal

N/A

Logo Insmed Incorporated

INSM

Insmed Incorporated

N/A

Current Price

$142.22

Market Cap

22.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FTI
INSM
Founded
1884
1988
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.8B
22.4B
IPO Year
2016
2000

Fundamental Metrics

Financial Performance
Metric
FTI
INSM
Price
$59.15
$142.22
Analyst Decision
Buy
Strong Buy
Analyst Count
22
24
Target Price
$76.45
★ $194.18
AVG Volume (30 Days)
2.7M
★ 3.9M
Earning Date
10-29-2026
10-29-2026
Dividend Yield
★ 0.33%
N/A
EPS Growth
★ 20.42
N/A
EPS
★ 2.59
N/A
Revenue
★ $9,932,600,000.00
N/A
Revenue This Year
$9.11
$206.90
Revenue Next Year
$5.42
$60.68
P/E Ratio
$23.67
★ N/A
Revenue Growth
★ 9.35
N/A
52 Week Low
$43.34
$90.39
52 Week High
$80.70
$212.75

Technical Indicators

Market Signals
Indicator
FTI
INSM
Relative Strength Index (RSI) 30.80 74.43
Support Level N/A $135.73
Resistance Level $71.95 $142.90
Average True Range (ATR) 2.38 7.04
MACD -0.39 3.18
Stochastic Oscillator 2.76 83.03

Price Performance

Historical Comparison
FTI
INSM

About FTI TechnipFMC plc

TechnipFMC PLC is the key provider of offshore oilfield services, offering integrated deep-water offshore oil and gas development solutions that span the full spectrum of subsea equipment and subsea construction services. The company also provides various pieces of surface equipment used with onshore oil and gas wells. TechnipFMC originated with the 2017 merger of Technip and FMC Technologies. Geographically it operates in Latin America generating the maximum revenue, then Europe and Central Asia, Africa, North America, Asia Pacific and Middle East.

About INSM Insmed Incorporated

Insmed Inc is a biopharmaceutical company. Its commercial portfolio and clinical pipeline are organized around three therapeutic areas: Respiratory, Immunology and Inflammation, and Neuro and Other Rare. The company's two commercial products, Arikayce and Brinsupri, are both part of the Respiratory therapeutic area. The firm's clinical-stage programs are TPIP, INS1148, brensocatib, and INS1201, focusing on different therapeutic areas. Additionally, Insmed's pre-clinical research programs encompass various technologies and modalities, including gene therapy, AI-driven protein engineering, protein manufacturing, RNA end-joining, and synthetic rescue. Geographically, the company generates maximum revenue from the United States from the sale of its commercial products.

Share on Social Networks: